LIGAND PHARMACEUTICALS INCORPORATED Impairment of Real Estate
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Impairment of Real Estate of $900.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfRealEstate · last filed 2023-11-09
- LIGAND PHARMACEUTICALS INCORPORATED impairment of real estate for the quarter ending 2023-09-30 was $900.00K.
| Period end | Impairment of Real Estate 3 month | Impairment of Real Estate 9 month |
|---|---|---|
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-09 | $900.00K 10-Q · filed 2023-11-09 |